RaySearch Laboratories AB (publ) Total Assets
RaySearch Laboratories AB (publ) total assets. Based on the latest financial reports, RaySearch Laboratories AB (publ) (RAY-B) holds total assets worth Skr1.82 Billion SEK (≈ $195.51 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see RAY-B market cap for the company's overall valuation and market capitalisation.
Total Assets of RaySearch Laboratories AB (publ) (2003–2025)
Total assets of RaySearch Laboratories AB (publ) from 2003 to 2025. This chart illustrates how RaySearch Laboratories AB (publ)'s total assets have evolved over time, based on quarterly financial data. See today's stock price for RaySearch Laboratories AB (publ) for real-time trading data and today's change.
RaySearch Laboratories AB (publ) - Asset Composition Analysis
RaySearch Laboratories AB (publ) Total Assets Breakdown (December 2025)
RaySearch Laboratories AB (publ) total assets breakdown as of December 2025. RaySearch Laboratories AB (publ)'s total assets of Skr1.82 Billion consist of 48.7% current assets and 51.3% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr407.30 Million | 20.5% |
| Accounts Receivable | Skr541.40 Million | 27.2% |
| Inventory | Skr22.00 Million | 1.1% |
| Property, Plant & Equipment | Skr447.30 Million | 22.5% |
| Intangible Assets | Skr558.70 Million | 28.1% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2003–2025)
This chart illustrates how RaySearch Laboratories AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore RAY-B working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RaySearch Laboratories AB (publ)'s current assets represent 48.7% of total assets in 2025, a decrease from 74.1% in 2003.
- Cash Position: Cash and equivalents constituted 20.5% of total assets in 2025, up from 20.2% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 18.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 28.1% of total assets.
RaySearch Laboratories AB (publ) Competitors by Total Assets
Key competitors of RaySearch Laboratories AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Echoiq Ltd
AU:EIQ
|
Australia | AU$17.99 Million |
|
Intrasense
PA:ALINS
|
France | €4.99 Million |
|
Pro Medicus Ltd
AU:PME
|
Australia | AU$610.14 Million |
|
Cogstate Ltd
AU:CGS
|
Australia | AU$64.77 Million |
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$92.19 Million |
|
Alcidion Group Ltd
AU:ALC
|
Australia | AU$115.63 Million |
|
Oneview Healthcare Plc
AU:ONE
|
Australia | AU$15.49 Million |
|
AMA Corp PLC
PA:ALAMA
|
France | €7.97 Million |
RaySearch Laboratories AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.29 | 1.40 | 1.33 |
| Quick Ratio | 1.22 | 1.35 | 1.27 |
| Cash Ratio | 0.00 | 0.60 | 0.35 |
| Working Capital | Skr179.60 Million | Skr269.52 Million | Skr114.04 Million |
RaySearch Laboratories AB (publ) - Advanced Valuation Insights
This section examines the relationship between RaySearch Laboratories AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.49 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | -4.7% |
| Total Assets | Skr1.99 Billion |
| Market Capitalization | $575.08 Million USD |
Valuation Analysis
Below Book Valuation: The market values RaySearch Laboratories AB (publ)'s assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: RaySearch Laboratories AB (publ)'s assets decreased by 4.7% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for RaySearch Laboratories AB (publ) (2003–2025)
The table below shows the annual total assets of RaySearch Laboratories AB (publ) from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr1.99 Billion ≈ $214.37 Million |
-4.74% |
| 2024-12-31 | Skr2.09 Billion ≈ $225.04 Million |
+7.09% |
| 2023-12-31 | Skr1.95 Billion ≈ $210.14 Million |
+4.09% |
| 2022-12-31 | Skr1.88 Billion ≈ $201.88 Million |
+7.87% |
| 2021-12-31 | Skr1.74 Billion ≈ $187.15 Million |
+35.34% |
| 2020-12-31 | Skr1.28 Billion ≈ $138.28 Million |
+1.64% |
| 2019-12-31 | Skr1.26 Billion ≈ $136.05 Million |
+14.37% |
| 2018-12-31 | Skr1.11 Billion ≈ $118.96 Million |
+20.80% |
| 2017-12-31 | Skr915.06 Million ≈ $98.48 Million |
+27.58% |
| 2016-12-31 | Skr717.25 Million ≈ $77.19 Million |
+48.04% |
| 2015-12-31 | Skr484.49 Million ≈ $52.14 Million |
+24.31% |
| 2014-12-31 | Skr389.75 Million ≈ $41.94 Million |
+30.28% |
| 2013-12-31 | Skr299.16 Million ≈ $32.19 Million |
+2.09% |
| 2012-12-31 | Skr293.03 Million ≈ $31.53 Million |
+12.27% |
| 2011-12-31 | Skr261.00 Million ≈ $28.09 Million |
+1.98% |
| 2010-12-31 | Skr255.93 Million ≈ $27.54 Million |
+9.79% |
| 2009-12-31 | Skr233.10 Million ≈ $25.09 Million |
+23.93% |
| 2008-12-31 | Skr188.09 Million ≈ $20.24 Million |
+8.58% |
| 2007-12-31 | Skr173.23 Million ≈ $18.64 Million |
+18.43% |
| 2006-12-31 | Skr146.27 Million ≈ $15.74 Million |
+36.47% |
| 2005-12-31 | Skr107.18 Million ≈ $11.53 Million |
+135.99% |
| 2004-12-31 | Skr45.42 Million ≈ $4.89 Million |
+47.67% |
| 2003-12-31 | Skr30.76 Million ≈ $3.31 Million |
-- |
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment co… Read more